The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery
出版年份 2021 全文链接
标题
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery
作者
关键词
-
出版物
JAMA Surgery
Volume 156, Issue 3, Pages e206363
出版商
American Medical Association (AMA)
发表日期
2021-01-28
DOI
10.1001/jamasurg.2020.6363
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Meta‐analysis of the molecular associations of mucinous colorectal cancer
- (2019) I. S. Reynolds et al. BRITISH JOURNAL OF SURGERY
- Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei
- (2019) Alessandra Raimondi et al. Clinical Colorectal Cancer
- Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
- (2019) Pierre-Emmanuel Bonnot et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival
- (2018) Joel M. Baumgartner et al. ANNALS OF SURGICAL ONCOLOGY
- Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei
- (2018) Kim Govaerts et al. EJSO
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) Willemien J. van Driel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unknown
- (2018) JOURNAL OF SURGICAL ONCOLOGY
- HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
- (2018) Wim Ceelen EJSO
- Toward the molecular dissection of peritoneal pseudomyxoma
- (2016) F. Pietrantonio et al. ANNALS OF ONCOLOGY
- GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study
- (2016) Filippo Pietrantonio et al. Journal of Translational Medicine
- Unknown
- (2016) STATISTICS IN MEDICINE
- Unknown
- (2016) CANCER
- The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
- (2015) S. Kusamura et al. EJSO
- Unknown
- (2015) STATISTICS IN MEDICINE
- Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
- (2014) Sunila Pradeep et al. CANCER CELL
- FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma
- (2014) F. Pietrantonio et al. ONCOLOGIST
- Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States
- (2013) K. Turaga et al. ANNALS OF SURGICAL ONCOLOGY
- The effects of the intraperitoneal administration of oxaliplatin and 5-FU on the healing of colonic anastomoses: an experimental study
- (2011) D. Kanellos et al. Techniques in Coloproctology
- Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach
- (2009) Paul H Sugarbaker EXPERT OPINION ON PHARMACOTHERAPY
- A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei
- (2008) A L Farquharson et al. BRITISH JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search